0001104659-24-061319.txt : 20240514
0001104659-24-061319.hdr.sgml : 20240514
20240514200137
ACCESSION NUMBER: 0001104659-24-061319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240512
FILED AS OF DATE: 20240514
DATE AS OF CHANGE: 20240514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schlessinger Sam
CENTRAL INDEX KEY: 0001914168
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39294
FILM NUMBER: 24946635
MAIL ADDRESS:
STREET 1: 100 SOUTH SAUNDERS ROAD, SUITE 300
CITY: LAKE FORREST
STATE: IL
ZIP: 60045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Assertio Holdings, Inc.
CENTRAL INDEX KEY: 0001808665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850598378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: (224) 419-7106
MAIL ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
tm2414464-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-12
0
0001808665
Assertio Holdings, Inc.
ASRT
0001914168
Schlessinger Sam
ASSERTIO HOLDINGS, INC.
100 SOUTH SANDERS ROAD, SUITE 300
LAKE FORREST
IL
60045
0
1
0
0
SVP, General Counsel
0
Common Stock
2024-05-12
4
M
0
38017
0
A
138895
D
Common Stock
2024-05-12
4
F
0
16840
0.96
D
122055
D
Restricted Stock Units
0.0
2024-05-12
4
M
0
38017
0
D
2025-05-12
Common Stock
38017
38017
D
Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
One-third of these restricted stock units are scheduled to vest on each of May 12, 2023, 2024 and 2025, assuming continued employment through the applicable vesting date.
The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
/s/ Sam Schlessinger
2024-05-14